Xvivo Perfusion AB

21
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: SE0004840718
SEK
178.90
7.3 (4.25%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Xvivo Perfusion AB Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
No of Months
12
12
12
12
12
12
Profit Before Tax
199.00
94.00
22.00
6.00
-57.00
5.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-79.00
-39.00
-22.00
-23.00
-4.00
-1.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
111.00
46.00
27.00
-12.00
-12.00
29.00
Cash Flow from Investing Activities
-243.00
-161.00
-197.00
-187.00
-266.00
-83.00
Cash Flow from Financing Activities
-10.00
418.00
-6.00
234.00
482.00
25.00
Net Cash Inflow / Outflow
-130.00
299.00
-152.00
44.00
194.00
-27.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
12.00
-3.00
24.00
9.00
-9.00
1.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in SEK Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Xvivo Perfusion AB
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(SEK)
Change(%)
Profit Before Tax
199.948
328
-129.00
-39.04%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-79.115
44
-123.00
-279.81%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
111.29
413
-302.00
-73.05%
Cash Flow from Investing Activities
-243.814
-456
213.00
46.53%
Cash Flow from Financing Activities
-10.902
-156
146.00
93.01%
Net Cash Inflow / Outflow
-130.567
-160
30.00
18.40%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
12.859
39
-27.00
-67.03%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'24
stock-summary

YoY Growth in year ended Dec 2024 is 140.43% vs 66.17% in Dec 2023

Dec'24
Dec'23
Change(%)
Cash Flow from Operating Activities
111.29
46.29
140.43%